The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pregnancy, High-Risk

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pregnancy, High-Risk


Psychiatry related information on Pregnancy, High-Risk

  • The High-Risk Pregnancy Stress Scale, Brown's Social Behaviors Inventory, and the Family Assessment Measure III Dyadic Relationships Scale were administered to the women at randomisation (T1) and at 1-week (T2) and 2-weeks (T3) after randomisation [6].

High impact information on Pregnancy, High-Risk


Chemical compound and disease context of Pregnancy, High-Risk


Biological context of Pregnancy, High-Risk


Anatomical context of Pregnancy, High-Risk


Associations of Pregnancy, High-Risk with chemical compounds


Gene context of Pregnancy, High-Risk


Analytical, diagnostic and therapeutic context of Pregnancy, High-Risk


  1. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. Schiff, E., Peleg, E., Goldenberg, M., Rosenthal, T., Ruppin, E., Tamarkin, M., Barkai, G., Ben-Baruch, G., Yahal, I., Blankstein, J. N. Engl. J. Med. (1989) [Pubmed]
  2. Natural progesterone prevents preterm birth in high-risk pregnancies. Pomianowski, K. The Journal of family practice. (2003) [Pubmed]
  3. Pregnancy and its complications following cardiac valve prostheses. Lutz, D.J., Noller, K.L., Spittell, J.A., Danielson, G.K., Fish, C.R. Am. J. Obstet. Gynecol. (1978) [Pubmed]
  4. Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Angel, J.L., O'Brien, W.F., Finan, M.A., Morales, W.J., Lake, M., Knuppel, R.A. Obstetrics and gynecology. (1990) [Pubmed]
  5. Fetal demise following negative contraction stress tests. Evertson, L.R., Gauthier, R.J., Collea, J.V. Obstetrics and gynecology. (1978) [Pubmed]
  6. A controlled clinical trial of home care management versus hospital care management for preterm labour. Goulet, C., Gévry, H., Gauthier, R.J., Lepage, L., Fraser, W., Aita, M. International journal of nursing studies. (2001) [Pubmed]
  7. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. Goland, R.S., Jozak, S., Warren, W.B., Conwell, I.M., Stark, R.I., Tropper, P.J. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  8. A simple specific assay for estriol in maternal urine. Davis, S.E., Loriaux, D.L. J. Clin. Endocrinol. Metab. (1975) [Pubmed]
  9. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Hunt, B.J., Doughty, H.A., Majumdar, G., Copplestone, A., Kerslake, S., Buchanan, N., Hughes, G., Khamashta, M. Thromb. Haemost. (1997) [Pubmed]
  10. Angiogenesis in the placenta. Reynolds, L.P., Redmer, D.A. Biol. Reprod. (2001) [Pubmed]
  11. Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Shirey, R.S., Mirabella, D.C., Lumadue, J.A., Ness, P.M. Transfusion (1997) [Pubmed]
  12. Diurnal variations in unconjugated plasma and total urinary estriol levels in late normal pregnancy. Bernstein, D., Zer, J., Zakut, H. Gynecol. Endocrinol. (1989) [Pubmed]
  13. Management of breast cancer in patients prenatally exposed to diethylstilbestrol: are we prepared? Mano, M.S., Kerr, J., Kennedy, J. Breast (Edinburgh, Scotland) (2005) [Pubmed]
  14. Appraisal of "rigid" blood glucose control during pregnancy in the overtly diabetic woman. Leveno, K.J., Hauth, J.C., Gilstrap, L.C., Whalley, P.J. Am. J. Obstet. Gynecol. (1979) [Pubmed]
  15. Obstetric technologies: what determines clinical acceptance or rejection of results of randomized controlled trials? Parer, J.T. Am. J. Obstet. Gynecol. (2003) [Pubmed]
  16. The early pregnancy factor (EPF) in pregnancies of women with habitual abortions. Gerhard, I., Katzer, E., Runnebaum, B. Early Hum. Dev. (1991) [Pubmed]
  17. Local administration of prostaglandin E2 for cervical ripening and labor induction: the appropriate route and dose. Nuutila, M., Kajanoja, P. Acta obstetricia et gynecologica Scandinavica. (1996) [Pubmed]
  18. Fetal activity determination and neosynephrine test for evaluation of fetal well-being in high risk pregnancies. Eguchi, K., Yonezawa, M., Hasegawa, T., Lin, T.T., Ejiri, K., Kudo, T., Sekiba, K., Takeda, Y. Nippon Sanka Fujinka Gakkai Zasshi (1980) [Pubmed]
  19. Amniotic fluid cortisol as an index of fetal lung maturity. Gewolb, I.H., Hobbins, J.C., Tan, S.Y. Obstetrics and gynecology. (1977) [Pubmed]
  20. S100B testing in pregnancy. Michetti, F., Gazzolo, D. Clin. Chim. Acta (2003) [Pubmed]
  21. Fetal and maternal Doppler velocimetry and cytokines in high-risk pregnancy. Dubiel, M., Seremak-Mrozikiewicz, A., Breborowicz, G.H., Drews, K., Pietryga, M., Gudmundsson, S. Journal of perinatal medicine. (2005) [Pubmed]
  22. Diethylstilbestrol-induced cervical and vaginal adenosis using the neonatal mouse model. Prahalada, S., Castracane, V.D., Hendrickx, A.G., Goldzieher, J.W. Biol. Reprod. (1988) [Pubmed]
  23. Induction of labor with oral prostaglandin E2 in normal and high-risk pregnancies. Nelson, G.H., Bryans, C.I. Am. J. Obstet. Gynecol. (1978) [Pubmed]
  24. Plasma oestriol and human placental lactogen measurements in patients with high risk pregnancies. Edwards, R.P., Diver, M.J., Davis, J.C., Hipkin, L.J. British journal of obstetrics and gynaecology. (1976) [Pubmed]
  25. Fetal breathing movements in high risk pregnancy. Trudinger, B.J., Lewis, P.J., Mangez, J., O'Connor, E. British journal of obstetrics and gynaecology. (1978) [Pubmed]
  26. A rapid method for the measurement of estradiol and hydrocortisone levels in maternal and fetal blood and amniotic fluid. Sybulski, S., Maughan, G.B. Am. J. Obstet. Gynecol. (1975) [Pubmed]
  27. Amniotic fluid disaccharidases in the prenatal detection of cystic fibrosis. Kleijer, W.J., Janse, H.C., van Diggelen, O.P., Niermeijer, M.F. Prenat. Diagn. (1985) [Pubmed]
  28. Carcinoembryonic antigen in high risk pregnancies. Lolis, D., Baltoyiannis, P., Messinis, I.E. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. (1984) [Pubmed]
  29. Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Read, A.P., Donnai, D., Harris, R., Donnai, P. British journal of obstetrics and gynaecology. (1980) [Pubmed]
  30. Plasma unconjugated estriol values in high-risk pregnancy. Bashore, R.A., Westlake, J.R. Am. J. Obstet. Gynecol. (1977) [Pubmed]
  31. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units. Hauth, J., Sibai, B., Caritis, S., VanDorsten, P., Lindheimer, M., Klebanoff, M., MacPherson, C., Landon, M., Paul, R., Miodovnik, M., Meis, P., Dombrowski, M., Thurnau, G., Walsh, S., McNellis, D., Roberts, J.M. Am. J. Obstet. Gynecol. (1998) [Pubmed]
  32. Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study. Linder, N., Levit, O., Klinger, G., Kogan, I., Levy, I., Shalit, I., Ashkenazi, S., Sirota, L. J. Hosp. Infect. (2004) [Pubmed]
  33. Prenatal diagnosis to exclude FAP in a high risk pregnancy. Dalton, A., Shannon, N.L., Johnson, M., Cook, J. Prenat. Diagn. (1998) [Pubmed]
  34. Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Stepan, H., Heihoff-Klose, A., Faber, R. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. (2004) [Pubmed]
WikiGenes - Universities